Table 2.
Correlations between all the studied parameters. p value were determined by Spearman Rho test
| OSDI | Hours of VDT use | Meibometry | Eyelid margin irregularity | Eyelid margin hyperemia | Plugging of the MG offices | Quality of the MG secretion | Nasal conjunctival hyperemia | Temporal conjunctival hyperemia | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Hours of VDT use | r | 0.235 | ||||||||
| p | 0.010* | |||||||||
| Meibometry | r | − 0.074 | 0.034 | |||||||
| p | 0.424 | 0.711 | ||||||||
| Eyelid margin irregularity | r | 0.093 | 0.110 | − 0.103 | ||||||
| p | 0.311 | 0.234 | 0.263 | |||||||
| Eyelid margin hyperemia | r | 0.257 | 0.002 | − 0.011 | 0.287 | |||||
| p | 0.005* | 0.984 | 0.908 | 0.001* | ||||||
| Plugging of the MG offices | r | 0.172 | 0.141 | − 0.032 | 0.248 | 0.325 | ||||
| p | 0.060 | 0.123 | 0.731 | 0.006 | < 0.001* | |||||
| Quality of the MG secretion | r | 0.085 | 0.104 | − 0.170 | 0.141 | 0.217 | 0.372 | |||
| p | 0.356 | 0.261 | 0.063 | 0.124 | 0.017* | < 0.001* | ||||
| Nasal conjunctival hyperemia | r | 0.098 | − 0.046 | 0.056 | 0.181 | − 0.080 | 0.314 | 0.186 | ||
| p | 0.285 | 0.616 | 0.547 | 0.048* | 0.383 | < 0.001* | 0.042* | |||
| Temporal conjunctival hyperemia | r | 0.141 | − 0.013 | 0.174 | 0.151 | 0.128 | 0.383 | 0.217 | 0.430 | |
| p | 0.125 | 0.891 | 0.058 | 0.099 | 0.163 | < 0.001* | 0.017* | < 0.001* | ||
| MGLA | r | − 0.002 | − 0.023 | − 0.152 | 0.079 | 0.099 | 0.058 | 0.187 | 0.058 | 0.092 |
| p | 0.979 | 0.803 | 0.098 | 0.389 | 0.283 | 0.528 | 0.041* | 0.528 | 0.315 | |
*Statistically significant (p < 0.05)
OSDI—ocular surface disease index, VDT—video display terminals, MG—meibomian glands, MGLA—meibomian gland loss area